Tilray | TRLY - 市值

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 4.83B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	市值	更改		日
Akebia Therapeutics	USD 427M		297M	2025-12
Alaunos Therapeutics	USD 7M		2M	2026-03
Aurora Cannabis	CAD 193.82M		133.39M	2026-03
Avita Medical	AUD 105.47M		35.32M	2025-12
Canopy Growth	CAD 557.13M		99.33M	2026-03
Cronos Group	USD 958.02M		45.05M	2026-03
Dianthus Therapeutics	USD 4.58B		2.8B	2026-03
Divis Laboratories Ltd	INR 1.58T		118.27B	2026-03
Ionis Pharmaceuticals	USD 13.1B		642M	2026-06
IQVIA Holdings	USD 32.25B		3.62B	2026-06
Organigram Holdings	CAD 252.47M		59.69M	2026-03
Organon & Co	USD 1.57B		290M	2026-03
Revvity	USD 9.94B		1.03B	2026-03
Tectonic Therapeutic	USD 580M		190M	2026-03
Viatris	USD 15.73B		1.39B	2026-03
Xeris Pharmaceuticals	USD 1000M		303M	2026-03
Zealand Pharma A/S	33.35B		448.34M	2025-12